Literature DB >> 34363134

Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.

Sudhakar K Venkatesh1, Christopher L Welle2, Frank H Miller3, Kartik Jhaveri4, Kristina I Ringe5, John E Eaton6, Helen Bungay7, Lionel Arrivé8, Ahmed Ba-Ssalamah9, Aristeidis Grigoriadis10, Christoph Schramm11, Ann S Fulcher12.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder affecting the bile ducts and is characterized by biliary strictures, progressive liver parenchymal fibrosis, and an increased risk of hepatobiliary malignancies primarily cholangiocarcinoma (CCA). PSC may lead to portal hypertension, liver decompensation, and liver failure with the need for liver transplantation. Magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) are considered the imaging standard for diagnosis and follow-up in patients with PSC. Currently, there are no universally accepted reporting standards and definitions for MRI/MRCP features. Controversies exist about the definition of a high-grade stricture and there is no widely agreed approach to their management. The members of the MRI working group of the International Primary Sclerosing Cholangitis Study Group (IPSCSG) sought to define terminologies and reporting standards for describing MRI/MRCP features that would be applied to diagnosis and surveillance of disease progression, and potentially for evaluating treatment response in clinical trials. In this extensive review, the technique of MRI/MRCP and assessment of image quality for the evaluation of PSC is briefly described. The definitions and terminologies for severity and length of strictures, duct wall thickening and hyperenhancement, and liver parenchyma signal intensity changes are outlined. As CCA is an important complication of PSC, standardized reporting criteria for CCA developing in PSC are summarized. Finally, the guidelines for reporting important changes in follow-up MRI/MRCP studies are provided. KEY POINTS: • Primary sclerosing cholangitis is a chronic inflammatory disorder affecting the bile ducts, causing biliary strictures and liver fibrosis and an increased risk of cholangiocarcinoma. • This consensus document provides definitions and suggested reporting standards for MRI and MRCP features of primary sclerosing cholangitis, which will allow for a standardized approach to diagnosis, assessment of disease severity, follow-up, and detection of complications. • Standardized definitions and reporting of MRI/MRCP features of PSC will facilitate comparison between studies, promote longitudinal assessment during management, reduce inter-reader variability, and enhance the quality of care and communication between health care providers.
© 2021. European Society of Radiology.

Entities:  

Keywords:  Biliary strictures; Cholangiocarcinoma; Definition; Sclerosing cholangitis; Terminology

Mesh:

Year:  2021        PMID: 34363134     DOI: 10.1007/s00330-021-08147-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  47 in total

1.  Performance of magnetic resonance elastography in primary sclerosing cholangitis.

Authors:  John E Eaton; Bogdan Dzyubak; Sudhakar K Venkatesh; Thomas C Smyrk; Gregory J Gores; Richard L Ehman; Nicholas F LaRusso; Andrea A Gossard; Konstantinos N Lazaridis
Journal:  J Gastroenterol Hepatol       Date:  2016-06       Impact factor: 4.029

2.  Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis.

Authors:  Kristina I Ringe; Aristeidis Grigoriadis; Emina Halibasic; Frank Wacker; Michael P Manns; Christoph Schramm; Henrike Lenzen
Journal:  Hepatology       Date:  2019-02-23       Impact factor: 17.425

3.  Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.

Authors:  Hanno Ehlken; Raluca Wroblewski; Christophe Corpechot; Lionel Arrivé; Susanne Lezius; Johannes Hartl; Ulrike W Denzer; Ansgar W Lohse; Olivier Chazouilleres; Christoph Schramm
Journal:  Gut       Date:  2016-02-26       Impact factor: 23.059

4.  Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.

Authors:  Palak J Trivedi; Hannah Crothers; Jemma Mytton; Sofie Bosch; Tariq Iqbal; James Ferguson; Gideon M Hirschfield
Journal:  Gastroenterology       Date:  2020-05-20       Impact factor: 22.682

5.  Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression.

Authors:  Ana Ruiz; Sara Lemoinne; Fabrice Carrat; Christophe Corpechot; Olivier Chazouillères; Lionel Arrivé
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

6.  Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease.

Authors:  M K Porayko; R H Wiesner; N F LaRusso; J Ludwig; R L MacCarty; B L Steiner; C K Twomey; A R Zinsmeister
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

7.  Cross-sectional imaging in patients with primary sclerosing cholangitis: Single time-point liver or spleen volume is associated with survival.

Authors:  Pegah Khoshpouri; Maryam Ghadimi; Roya Rezvani Habibabadi; Mina Motaghi; Bharath Ambale Venkatesh; Mohammadreza Shaghaghi; Ankur Pandey; Bita Hazhirkarzar; Sanaz Ameli; Mounes Aliyari Ghasabeh; Pallavi Pandey; Ihab R Kamel
Journal:  Eur J Radiol       Date:  2020-10-04       Impact factor: 3.528

Review 8.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

9.  An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis.

Authors:  Jennifer Schulze; Henrike Lenzen; Jan B Hinrichs; Burckhardt Ringe; Michael P Manns; Frank Wacker; Kristina I Ringe
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-11       Impact factor: 11.382

10.  Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis.

Authors:  Ahmad Hassan Ali; James H Tabibian; Navine Nasser-Ghodsi; Ryan J Lennon; Thomas DeLeon; Mitesh J Borad; Moira Hilscher; Marina G Silveira; Elizabeth J Carey; Keith D Lindor
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

View more
  2 in total

Review 1.  Primary sclerosing cholangitis: review for radiologists.

Authors:  Matthew A Morgan; Rachita Khot; Karthik M Sundaram; Daniel R Ludwig; Rashmi T Nair; Pardeep K Mittal; Dhakshina M Ganeshan; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2022-09-05

Review 2.  MR elastography in primary sclerosing cholangitis: a pictorial review.

Authors:  Christopher L Welle; Patrick J Navin; Michael C Olson; Safa Hoodeshenas; Michael S Torbenson; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2022-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.